TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
Study Details
Study Description
Brief Summary
Hypothesis: The investigators hypothesize that genetic variants will alter gene expression in response to ischemia during cardiopulmonary bypass. To test this, the investigators will be taking small pieces of heart tissue from patients undergoing heart surgery before and after this period of ischemia. This will be compared to blood gene expression in blood cells and analyzed with the patients' genetic profile. This might allow us to assess the amount of inflammation that occurs when patients are on the heart-lung machine as well as examine the effects genes have on this critical time period.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Differential gene expression [Immediate]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Aged greater than 20 years
-
Undergoing aortic valve surgery with or without CABG surgery
-
Receive and apical vent as part of the surgery
Exclusion Criteria:
- Will not receive an apical left ventricular vent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Brigham and Women's Hospital | Boston | Massachusetts | United States | 02115 |
Sponsors and Collaborators
- Brigham and Women's Hospital
- American Heart Association
- Harvard Medical School (HMS and HSDM)
- National Heart, Lung, and Blood Institute (NHLBI)
Investigators
- Principal Investigator: Jochen D. Muehlschlegel, MD, Brigham and Women's Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2007p002323
- R01HL118266